FDA Declines to Approve MDMA Therapy, and Seeks Further Study

FDA Declines to Approve MDMA Therapy, and Seeks Further Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy. Psychedelic and Hallucinogenic Drugs, Ecstasy (Drug), Post-Traumatic Stress Disorder, Lykos Therapeutics, Veterans, Therapy and Rehabilitation, Psychology and Psychologists, Mental Health and Disorders, Clinical Trials, Research, Food and Drug Administration, Regulation and Deregulation of Industry NYT > Health

​The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy. 

Leave a Reply

Your email address will not be published. Required fields are marked *